$DARE
Dare Bioscience, Inc.

2022 Q4 Form 10-Q Financial Statement

#000140191422000087 Filed on November 10, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $3.254M $2.677M
YoY Change 34.09% 19.68%
% of Gross Profit
Research & Development $12.98M $4.462M
YoY Change 82.35% -57.23%
% of Gross Profit
Depreciation & Amortization $10.62K $3.030K
YoY Change 50.85% -52.28%
% of Gross Profit
Operating Expenses $16.23M $7.139M
YoY Change 70.08% -43.65%
Operating Profit -$7.139M
YoY Change -43.65%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $287.3K $119.0K
YoY Change 34519.28% 7787.93%
Pretax Income -$15.94M -$7.020M
YoY Change 67.08% -44.58%
Income Tax
% Of Pretax Income
Net Earnings -$15.94M -$7.020M
YoY Change 67.08% -44.58%
Net Earnings / Revenue
Basic Earnings Per Share -$0.08
Diluted Earnings Per Share -$0.20 -$0.08
COMMON SHARES
Basic Shares Outstanding 84.83M shares 84.82M shares
Diluted Shares Outstanding 84.82M shares

Balance Sheet

Concept 2022 Q4 2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $34.67M $40.39M
YoY Change -32.91% -11.37%
Cash & Equivalents $34.67M $40.39M
Short-Term Investments
Other Short-Term Assets $6.666M $6.886M
YoY Change 169.16% 173.65%
Inventory
Prepaid Expenses $6.666M $6.885M
Receivables
Other Receivables $1.703M $2.292M
Total Short-Term Assets $43.04M $49.57M
YoY Change -22.17% 2.74%
LONG-TERM ASSETS
Property, Plant & Equipment $64.91K $72.83K
YoY Change 149.25% 120.12%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $722.7K $736.5K
YoY Change 48.98% 37.61%
Total Long-Term Assets $787.6K $809.3K
YoY Change 54.09% 42.41%
TOTAL ASSETS
Total Short-Term Assets $43.04M $49.57M
Total Long-Term Assets $787.6K $809.3K
Total Assets $43.83M $50.38M
YoY Change -21.47% 3.21%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.028M $3.477M
YoY Change -3.57% 474.05%
Accrued Expenses $10.89M $4.136M
YoY Change 247.36% 9.52%
Deferred Revenue $0.00
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $31.62M $22.84M
YoY Change 97.0% 43.57%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.090M $1.195M
YoY Change 17.6%
Total Long-Term Liabilities $1.090M $1.195M
YoY Change 17.6%
TOTAL LIABILITIES
Total Short-Term Liabilities $31.62M $22.84M
Total Long-Term Liabilities $1.090M $1.195M
Total Liabilities $32.71M $24.03M
YoY Change 91.84% 42.01%
SHAREHOLDERS EQUITY
Retained Earnings -$141.1M -$125.1M
YoY Change 28.12% 24.35%
Common Stock $152.5M $152.0M
YoY Change 2.35% 14.6%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $11.11M $26.34M
YoY Change
Total Liabilities & Shareholders Equity $43.83M $50.38M
YoY Change -21.47% 3.21%

Cashflow Statement

Concept 2022 Q4 2022 Q3
OPERATING ACTIVITIES
Net Income -$15.94M -$7.020M
YoY Change 67.08% -44.58%
Depreciation, Depletion And Amortization $10.62K $3.030K
YoY Change 50.85% -52.28%
Cash From Operating Activities -$5.897M $8.600M
YoY Change -40.53% 551.37%
INVESTING ACTIVITIES
Capital Expenditures $2.700K -$55.00K
YoY Change 278.79%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$2.700K -$55.00K
YoY Change 278.79%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -10.00 4.460K
YoY Change -100.0% -99.99%
NET CHANGE
Cash From Operating Activities -5.897M 8.600M
Cash From Investing Activities -2.700K -55.00K
Cash From Financing Activities -10.00 4.460K
Net Change In Cash -5.899M 8.550M
YoY Change -196.9% -76.59%
FREE CASH FLOW
Cash From Operating Activities -$5.897M $8.600M
Capital Expenditures $2.700K -$55.00K
Free Cash Flow -$5.899M $8.655M
YoY Change -40.51% 548.4%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001401914
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
us-gaap Revenue From Contract With Customer Product And Service Extensible List
RevenueFromContractWithCustomerProductAndServiceExtensibleList
http://fasb.org/us-gaap/2022#LicenseMember
CY2022Q3 us-gaap Revenue From Contract With Customer Product And Service Extensible List
RevenueFromContractWithCustomerProductAndServiceExtensibleList
http://fasb.org/us-gaap/2022#LicenseMember
CY2022Q3 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
84825481 shares
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-36395
dei Entity Registrant Name
EntityRegistrantName
DARÉ BIOSCIENCE, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-4139823
dei Entity Address Address Line1
EntityAddressAddressLine1
3655 Nobel Drive
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 260
dei Entity Address City Or Town
EntityAddressCityOrTown
San Diego
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei City Area Code
CityAreaCode
858
dei Local Phone Number
LocalPhoneNumber
926-7655
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92122
dei Security12b Title
Security12bTitle
Common Stock
dei Trading Symbol
TradingSymbol
DARE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4136330 usd
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
40389546 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
51674087 usd
CY2022Q3 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
2292041 usd
CY2021Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
1145317 usd
CY2022Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
6885498 usd
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
2476612 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
49567085 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
55296016 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
72833 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
26041 usd
CY2022Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
736514 usd
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
485120 usd
CY2022Q3 us-gaap Assets
Assets
50376432 usd
CY2021Q4 us-gaap Assets
Assets
55807177 usd
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
3477192 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2103083 usd
CY2021Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1000000 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3136244 usd
CY2022Q3 dare Deferred Grant Funding Current
DeferredGrantFundingCurrent
14836416 usd
CY2021Q4 dare Deferred Grant Funding Current
DeferredGrantFundingCurrent
10542983 usd
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
388135 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
270546 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
22838073 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
16052856 usd
CY2022Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1000000 usd
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
194587 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0 usd
CY2022Q3 us-gaap Liabilities
Liabilities
24032660 usd
CY2021Q4 us-gaap Liabilities
Liabilities
17052856 usd
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
240000000 shares
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
240000000 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
84825481 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
84825481 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
83944119 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
83944119 shares
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
8482 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
8394 usd
CY2022Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-530740 usd
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-154973 usd
CY2022Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
151997447 usd
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
149027802 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-125131417 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-110126902 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
26343772 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
38754321 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
50376432 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
55807177 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0 usd
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5949299 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
10000000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0 usd
CY2022Q3 us-gaap Revenues
Revenues
0 usd
CY2021Q3 us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
10000000 usd
us-gaap Revenues
Revenues
0 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2651543 usd
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2211334 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8014424 usd
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4462250 usd
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10432603 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
17065497 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
23501098 usd
CY2022Q3 dare License Fee
LicenseFee
25000 usd
CY2021Q3 dare License Fee
LicenseFee
25000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-15154921 usd
dare License Fee
LicenseFee
75000 usd
dare License Fee
LicenseFee
75000 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
7138793 usd
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
12668937 usd
us-gaap Operating Expenses
OperatingExpenses
25154921 usd
us-gaap Operating Expenses
OperatingExpenses
29525397 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-7138793 usd
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-12668937 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-29525397 usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
118950 usd
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1508 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
150406 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1686 usd
CY2022Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2021Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
369887 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-7019843 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-12667429 usd
us-gaap Net Income Loss
NetIncomeLoss
-15004515 usd
us-gaap Net Income Loss
NetIncomeLoss
-29153824 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-230748 usd
CY2021Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-63281 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-375767 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-79002 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-7250591 usd
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-12730710 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-15380282 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-29232826 usd
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.18
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.18
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.18
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.18
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.45
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.45
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
84822516 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
84822516 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
70775508 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
70775508 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
85553134 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
85553134 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
64196162 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
64196162 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
38754321 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
532409 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-8398670 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-9150 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
30878910 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
537521 usd
CY2022Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1218750 usd
CY2022Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
120149 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
413998 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-135869 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
33033459 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
556448 usd
CY2022Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4456 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-7019843 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-230748 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
26343772 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-1151733 usd
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
365911 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
31888591 usd
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
11324140 usd
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
50400 usd
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-7323644 usd
CY2021Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-6841 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
3258233 usd
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
405478 usd
CY2021Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
13251924 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-9162751 usd
CY2021Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-8880 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
7744004 usd
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
439497 usd
CY2021Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
35012048 usd
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
204466 usd
CY2021Q3 dare Stock Issued During Period Value Milestone Payment
StockIssuedDuringPeriodValueMilestonePayment
1219286 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-12667429 usd
CY2021Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-63281 usd
us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
46477 usd
us-gaap Net Income Loss
NetIncomeLoss
-15004515 usd
us-gaap Net Income Loss
NetIncomeLoss
-29153824 usd
us-gaap Depreciation
Depreciation
13580 usd
us-gaap Depreciation
Depreciation
19366 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1626378 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1210886 usd
dare Non Cash Lease Expense
NonCashLeaseExpense
29320 usd
dare Non Cash Lease Expense
NonCashLeaseExpense
-69356 usd
us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
0 usd
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
0 usd
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
44286 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
369887 usd
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
1146724 usd
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-303921 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
4408886 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
661849 usd
dare Increase Decrease In Other Non Current Assets And Deferred Charges
IncreaseDecreaseInOtherNonCurrentAssetsAndDeferredCharges
-77939 usd
dare Increase Decrease In Other Non Current Assets And Deferred Charges
IncreaseDecreaseInOtherNonCurrentAssetsAndDeferredCharges
-57247 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1374109 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-415602 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1000086 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
594629 usd
dare Increase Decrease In Deferred Grant Funding
IncreaseDecreaseInDeferredGrantFunding
-4293433 usd
dare Increase Decrease In Deferred Grant Funding
IncreaseDecreaseInDeferredGrantFunding
-9592045 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-12191757 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-18848138 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
60372 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
14524 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-60372 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-14524 usd
dare Net Proceeds From Issuance Of Common Stock And Warrants
NetProceedsFromIssuanceOfCommonStockAndWarrants
1218750 usd
dare Net Proceeds From Issuance Of Common Stock And Warrants
NetProceedsFromIssuanceOfCommonStockAndWarrants
59588112 usd
dare Noncash Or Part Noncash Acquisition Common Stock Issued For Settlement Of Contingent Consideration Liability
NoncashOrPartNoncashAcquisitionCommonStockIssuedForSettlementOfContingentConsiderationLiability
0 usd
dare Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
124605 usd
dare Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
254866 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1343355 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
59842978 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-375767 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-79002 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-11284541 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
40901314 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
51674087 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4669467 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
40389546 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
45570781 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
585942 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
308533 usd
dare Forgiveness Of Paycheck Protection Program Note Payable
ForgivenessOfPaycheckProtectionProgramNotePayable
0 usd
dare Forgiveness Of Paycheck Protection Program Note Payable
ForgivenessOfPaycheckProtectionProgramNotePayable
369887 usd
dare Noncash Or Part Noncash Acquisition Common Stock Issued For Settlement Of Contingent Consideration Liability
NoncashOrPartNoncashAcquisitionCommonStockIssuedForSettlementOfContingentConsiderationLiability
925000 usd
dare Milestone Payments Contingent Amount
MilestonePaymentsContingentAmount
0 usd
dare Milestone Payments Contingent Amount
MilestonePaymentsContingentAmount
250000 usd
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
400000 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-125100000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
40400000 usd
CY2022Q3 dare Deferred Grant Funding Current
DeferredGrantFundingCurrent
14800000 usd
CY2022Q3 dare Working Capital Increase Deficit
WorkingCapitalIncreaseDeficit
26700000 usd
us-gaap Net Income Loss
NetIncomeLoss
-15000000 usd
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
12200000 usd
dare Periodof Insufficient Cashand Liquidity Requirements
PeriodofInsufficientCashandLiquidityRequirements
P12M
CY2021Q4 dare Percentage Of Aggregate Commission
PercentageOfAggregateCommission
0.03
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
751000 shares
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1300000 usd
dare Offering Expenses
OfferingExpenses
42000 usd
CY2021Q2 dare Percentage Of Aggregate Commission
PercentageOfAggregateCommission
0.03
CY2018Q1 dare Percentage Of Aggregate Commission
PercentageOfAggregateCommission
0.030
CY2021Q4 dare Deferred Offering Costs Unamortized Portion
DeferredOfferingCostsUnamortizedPortion
0 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
7000000 usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
207000 usd
CY2018Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
3.00
CY2019Q2 us-gaap Warrant Exercise Price Decrease
WarrantExercisePriceDecrease
0.98
CY2020Q3 us-gaap Warrant Exercise Price Decrease
WarrantExercisePriceDecrease
0.96
CY2019Q2 dare Deemed Dividend From Trigger Of Round Down Provision Feature
DeemedDividendFromTriggerOfRoundDownProvisionFeature
800000 usd
CY2020Q3 dare Deemed Dividend From Trigger Of Round Down Provision Feature
DeemedDividendFromTriggerOfRoundDownProvisionFeature
6863 usd
dare Number Of Common Stock Warrants Exercised
NumberOfCommonStockWarrantsExercised
0 shares
dare Number Of Common Stock Warrants Exercised
NumberOfCommonStockWarrantsExercised
265485 shares
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
254866 usd
CY2022Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1381015 shares
CY2022Q3 us-gaap Deferred Compensation Sharebased Arrangements Liability Current And Noncurrent
DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent
4700000 usd
dare Weighted Average Amortization Period
WeightedAverageAmortizationPeriod
P2Y6M21D
CY2018Q3 us-gaap Net Rentable Area
NetRentableArea
3169 sqft
CY2022Q1 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P2Y
CY2022Q3 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-504000 usd
dare Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
-458000 usd
us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
46000 usd
CY2022Q3 us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
46000 usd
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
546000 usd
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
388000 usd
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
195000 usd
CY2022Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
116000 usd
CY2021Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
134000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
469000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
420000 usd
CY2022Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
81000 usd
CY2021Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
117000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
231000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
343000 usd
CY2022Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y6M29D
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
105000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
422000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
93000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
620000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
37000 usd
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7993569 shares
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
583000 usd
CY2020Q2 dare Coronavirus Aid Reliefand Economic Security Act Loan Proceeds Received
CoronavirusAidReliefandEconomicSecurityActLoanProceedsReceived
367285 usd
CY2021Q1 dare Notes Payable Current Plus Accrued Interest
NotesPayableCurrentPlusAccruedInterest
369887 usd
dare Proceeds From Award Of Grant
ProceedsFromAwardOfGrant
1900000 usd
dare Proceeds From Award Of Grant
ProceedsFromAwardOfGrant
19400000 usd
CY2022Q3 dare Deferred Grant Funding Current
DeferredGrantFundingCurrent
14800000 usd
CY2022Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7993569 shares
CY2021Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6445824 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6445824 shares

Files In Submission

Name View Source Status
0001401914-22-000087-index-headers.html Edgar Link pending
0001401914-22-000087-index.html Edgar Link pending
0001401914-22-000087.txt Edgar Link pending
0001401914-22-000087-xbrl.zip Edgar Link pending
dare-20220930.htm Edgar Link pending
dare-20220930.xsd Edgar Link pending
dare-20220930_g1.jpg Edgar Link pending
dare-20220930_cal.xml Edgar Link unprocessable
dare-20220930_def.xml Edgar Link unprocessable
exhibit311_20220930.htm Edgar Link pending
exhibit312_20220930.htm Edgar Link pending
exhibit321_20220930.htm Edgar Link pending
exhibit322_20220930.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
dare-20220930_htm.xml Edgar Link completed
dare-20220930_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
dare-20220930_pre.xml Edgar Link unprocessable